Antibody
|
Antigen Genes
|
Structure
|
Conditions
|
Figures
|
Ab1-aldoc
|
|
|
standard conditions
|
Fig. 2
from McFarland et al., 2008
|
Ab1-mnx1
|
|
|
standard conditions
|
Fig. 5
from Almeida et al., 2016
|
Ab1-rps6
|
|
|
standard conditions
|
Fig. 1
from Mathews et al., 2016
Fig. 4
from Kearns et al., 2015
|
Ab18-h3
|
|
|
standard conditions
|
Fig. 5
from Almeida et al., 2016
|
Ab4-sox10
|
|
|
control
|
Fig. 5
from Kim et al., 2015
|
zn-8
|
|
|
standard conditions
|
Fig. 3,
Fig. 6
from Zannino et al., 2009
Fig. 3
from Kim et al., 2008
|
Ab1-tuba
|
|
|
standard conditions
|
Fig. 3
from Yang et al., 2015
|
Ab1-calb2
|
|
|
standard conditions
|
Fig. 2
from McFarland et al., 2008
|
Ab4-sox10
|
|
|
chemical treatment: metronidazole, chemical treatment: sulfasalazine
|
Fig. 5
from Kim et al., 2015
|
Ab2-isl
|
|
|
standard conditions
|
Fig. 4
from Snyder et al., 2012
Fig. 3,
Fig. 6
from Zannino et al., 2009
|
Ab1-prkcz
|
|
|
control
|
Fig. 7
from Takada et al., 2011
|
Ab1-fabp7
|
|
|
standard conditions
|
Fig. 2,
Fig. 3
from Kim et al., 2008
|
Ab1-pax2
|
|
|
standard conditions
|
Fig. 8
from Zannino et al., 2009
|
Ab-G3G4
|
|
|
chemical treatment: 5-bromo-2'-deoxyuridine
|
Fig. 4
from Kim et al., 2008
|
Ab-3A10
|
|
|
standard conditions
|
Fig. 5
from Almeida et al., 2016
Fig. 1
from Mathews et al., 2014
|
Ab20-mapk
|
|
|
standard conditions
|
Fig. 1
from Mathews et al., 2016
|
ab1-lhx3/4
|
|
|
standard conditions
|
Fig. 2
from Seredick et al., 2014
|
Ab1-elavl
|
|
|
chemical treatment: drug
|
Fig. 1
from Takada et al., 2010
Fig. 5
from Kim et al., 2008
|
Ab1-dhrs12la
|
|
|
standard conditions
|
Fig. 1
from Nagarajan et al., 2019
|
zrf-1
|
|
|
standard conditions
|
Fig. 3
from Hudish et al., 2013
Fig. 7
from Takada et al., 2011
Fig. 1
from Takada et al., 2010
Fig. 8
from Zannino et al., 2009
Fig. 6
from Kim et al., 2008
Fig. 4 ,
Fig. S1
from Kim et al., 2008
|
Ab1-pvalb
|
|
|
standard conditions
|
Fig. 2
from McFarland et al., 2008
|
Ab20-mapk
|
|
|
chemical treatment by environment: Ro 48-8071
|
Fig. 1
from Mathews et al., 2016
|
Ab1-rps6
|
|
|
chemical treatment: sirolimus
|
Fig. 1
from Mathews et al., 2016
Fig. 4
from Kearns et al., 2015
|
Ab1-elavl
|
|
|
standard conditions
|
Fig. 2
from Shin et al., 2012
Fig. 1
from Takada et al., 2010
Fig. 5
from Bae et al., 2009
Fig. 8
from Zannino et al., 2009
Fig. 5
from Kim et al., 2008
Fig. 2
from McFarland et al., 2008
|
zrf-1
|
|
|
chemical treatment: DAPT
|
Fig. 1
from Takada et al., 2010
Fig. 6
from Kim et al., 2008
|
Ab1-fabp7a
|
fabp7a
|
|
standard conditions
|
Fig. 2
from Kim et al., 2008
|
Ab3-sox2
|
sox2
|
|
standard conditions
|
Fig. 4
from Snyder et al., 2012
|
Ab2-sox10
|
sox10
|
|
standard conditions
|
Fig. 1
from Piller et al., 2021
|
Ab1-sox10
|
|
|
standard conditions
|
16 figures
from
10 publications
|
Ab1-sox10
|
|
|
chemical treatment: drug
|
Fig. 1
from Takada et al., 2010
Fig. 5
from Kim et al., 2008
|